Literature DB >> 11233399

Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations.

H Tomita1, O Yamada, H Ohuchi, Y Ono, Y Arakaki, T Yagihara, S Echigo.   

Abstract

We analyzed retrospectively the relationship between coagulation profile, and either hepatic function or hemodynamics, in patients who had undergone a Fontan-type procedure, comparing them, first, with a control group of 12 patients without significant hemodynamic abnormality, and, second, with a group of 14 patients who had not undergone a Fontan procedure, but whose mean right atrial pressure exceeded 8 mmHg. Follow-up catheterization had been performed in all 30 patients submitted to the Fontan-type operation. Prothrombin time, and factor XIII, were significantly lower in those who had undergone the Fontan procedure than in the other groups. Those submitted to the Fontan operation also had lower levels of protein C than controls, and their levels of plasminogen were lower than the patients with high right atrial pressure. Both aspartate aminotransferase and alanine aminotransferase were higher in those undergoing the Fontan procedure than in the other groups, while gamma-glutamyltranspeptidase in these patients was higher than in the control group. Mean right atrial pressure was highest in those undergoing the Fontan procedure, while cardiac index was lowest. Prothrombin time was correlated to some extent with aspartate aminotransferase, mean right atrial pressure, and cardiac index. Protein C correlated with both aspartate aminotransferase and mean right atrial pressure, while factor XIII correlated with alanine aminotransferase, mean right atrial pressure, and cardiac index. Aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyltranspeptidase, parameters of hepatic function, correlated significantly with mean right atrial pressure. In those who had undergone the Fontan procedure, decreased synthesis of pro-and anti-coagulant factors is a risk factor for both thrombosis and bleeding. Abnormal hemodynamics, in the absence of a right sided pumping chamber, may predispose to subclinical hepatic dysfunction, leading to selective disturbances of protein synthesis.

Entities:  

Mesh:

Year:  2001        PMID: 11233399     DOI: 10.1017/s1047951100012439

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  13 in total

1.  Prophylactic anticoagulation following the Fontan operation.

Authors:  H A Walker; M A Gatzoulis
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

Review 2.  Four decades of Fontan palliation.

Authors:  Marc R de Leval; John E Deanfield
Journal:  Nat Rev Cardiol       Date:  2010-06-29       Impact factor: 32.419

Review 3.  Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis.

Authors:  Chiara Marrone; Gennaro Galasso; Raffaele Piccolo; Francesco de Leva; Rodolfo Paladini; Federico Piscione; Giuseppe Santoro
Journal:  Pediatr Cardiol       Date:  2010-10-22       Impact factor: 1.655

Review 4.  The Miracle Baby Grows Up: Hypoplastic Left Heart Syndrome in the Adult.

Authors:  Matthew Lewis; Marlon Rosenbaum
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

5.  Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up.

Authors:  V Chaloupecký; I Svobodová; I Hadacová; V Tomek; B Hucín; T Tláskal; J Janousek; O Reich; J Skovránek
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

Review 6.  Thromboembolic complications in adult congenital heart disease: the knowns and the unknowns.

Authors:  Magalie Ladouceur; Clément Karsenty; Victor Waldmann; Barbara Mulder; Sébastien Hascoet
Journal:  Clin Res Cardiol       Date:  2020-10-09       Impact factor: 5.460

7.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

8.  Risk factors and serological markers of liver cirrhosis after Fontan procedure.

Authors:  Mikiko Shimizu; Kenji Miyamoto; Yunosuke Nishihara; Gaku Izumi; Shuji Sakai; Kei Inai; Toshio Nishikawa; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2015-09-19       Impact factor: 2.037

9.  The Fontan pathway: What's down the road?

Authors:  Sachin Khambadkone
Journal:  Ann Pediatr Cardiol       Date:  2008-07

10.  Older Age at Completion of Fontan Procedure Is Associated with Improved Percentage of Predicted Maximum Oxygen Uptake.

Authors:  Elijah H Bolin; Shiraz A Maskatia; Amanda L Tate; Christopher J Petit
Journal:  Tex Heart Inst J       Date:  2015-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.